In this study, as expected, cognitive impairment was successfully observed in an in vivo T2DM rat model after a six-week intervention period, enabling the comparison and analysis of the effects of the combination of hesperetin and metformin on glucose metabolism, insulin levels, and cognitive abilities in diabetic rats. Here, INS is linked to type 2 diabetes mellitus.